Results 81 to 90 of about 43,195 (149)

An agent-based approach for modelling and simulation of glycoprotein VI receptor diffusion, localisation and dimerisation in platelet lipid rafts. [PDF]

Sci Rep, 2023
Tantiwong C, Dunster JL, Cavill R, Tomlinson MG, Wierling C, Heemskerk JWM, Gibbins JM.   +6 more
europepmc   +1 more source

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System. [PDF]

Arterioscler Thromb Vasc Biol, 2021
Perrella G, Nagy M, Watson SP, Heemskerk JWM.   +3 more
europepmc   +1 more source

Comprehensive analysis of glycoprotein VI-mediated platelet activation signaling pathway for predicting pan-cancer survival and response to anti-PD-1 immunotherapy. [PDF]

Comput Struct Biotechnol J, 2023
Chen S, Zhang L, Chen L, Huang Q, Wang Y, Liang Y.   +5 more
europepmc   +1 more source

Platelet receptor glycoprotein VI

Clinical & Experimental Thrombosis and Hemostasis, 2020
openaire   +1 more source

Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia. [PDF]

J Thromb Thrombolysis, 2023
Tantawy AAG, Elsherif NHK, Ebeid FS, El-Gamal RAE, Ismail EAR, Kenny MA, Morcos MBE.   +6 more
europepmc   +1 more source

Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3-mediated platelet activation to fibrinogen, thrombus buildup, and stability. [PDF]

Res Pract Thromb Haemost, 2021
Ahmed MU, Receveur N, Janus-Bell E, Mouriaux C, Gachet C, Jandrot-Perrus M, Hechler B, Gardiner EE, Mangin PH.   +8 more
europepmc   +1 more source

Platelet glycoprotein VI modulates leukocyte characteristics in sepsis-induced systemic inflammatory response in male mice. [PDF]

Physiol Rep
Corken A, Ware J, Thakali KM.
europepmc   +1 more source

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs. [PDF]

Eur Heart J
Mangin PH, Jandrot-Perrus M.
europepmc   +1 more source

A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1. [PDF]

Res Pract Thromb Haemost
Lamerton RE, Martin EM, Perry J, Cunningham AF, Watson SP, Frelinger AL.   +5 more
europepmc   +1 more source

The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice. [PDF]

Eur Heart J
Navarro S, Talucci I, Göb V, Hartmann S, Beck S, Orth V, Stoll G, Maric HM, Stegner D, Nieswandt B.   +9 more
europepmc   +1 more source